{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,12,3]],"date-time":"2024-12-03T05:05:07Z","timestamp":1733202307039,"version":"3.30.0"},"reference-count":99,"publisher":"Spandidos Publications","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncol Lett"],"DOI":"10.3892\/ol.2024.14768","type":"journal-article","created":{"date-parts":[[2024,10,23]],"date-time":"2024-10-23T10:39:06Z","timestamp":1729679946000},"source":"Crossref","is-referenced-by-count":0,"title":["Co\u2011occurrence of clear cell renal cell carcinoma and bladder urothelial carcinoma: A case report and literature review"],"prefix":"10.3892","volume":"29","author":[{"given":"Shuo","family":"Wu","sequence":"first","affiliation":[{"name":"Department of Urology, Huanghe Sanmenxia Hospital Affiliated to Henan University of Science and Technology, Sanmenxia, Henan 472000, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuliang","family":"Zuo","sequence":"additional","affiliation":[{"name":"Department of Urology, Huanghe Sanmenxia Hospital Affiliated to Henan University of Science and Technology, Sanmenxia, Henan 472000, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meihong","family":"Ye","sequence":"additional","affiliation":[{"name":"Department of Pathology, Huanghe Sanmenxia Hospital Affiliated to Henan University of Science and Technology, Sanmenxia, Henan 472000, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kuan","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Urology, Huanghe Sanmenxia Hospital Affiliated to Henan University of Science and Technology, Sanmenxia, Henan 472000, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaolong","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Urology, Huanghe Sanmenxia Hospital Affiliated to Henan University of Science and Technology, Sanmenxia, Henan 472000, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xudong","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Urology, Huanghe Sanmenxia Hospital Affiliated to Henan University of Science and Technology, Sanmenxia, Henan 472000, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chaoming","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Urology, Huanghe Sanmenxia Hospital Affiliated to Henan University of Science and Technology, Sanmenxia, Henan 472000, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2024,10,23]]},"reference":[{"key":"key20241202101834_b1-ol-29-1-14768","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"key20241202101834_b2-ol-29-1-14768","doi-asserted-by":"publisher","first-page":"2763","DOI":"10.1200\/JCO.2005.07.055","article-title":"Prognostic value of histologic subtypes in renal cell carcinoma: A multicenter experience","volume":"23","author":"Patard","year":"2005","journal-title":"J Clin Oncol"},{"key":"key20241202101834_b3-ol-29-1-14768","doi-asserted-by":"publisher","first-page":"4","DOI":"10.6004\/jnccn.2024.0008","article-title":"NCCN guidelines\u00ae insights: Kidney cancer, version 2.2024","volume":"22","author":"Motzer","year":"2024","journal-title":"J Natl Compr Canc Netw"},{"key":"key20241202101834_b4-ol-29-1-14768","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.humpath.2022.08.006","article-title":"The 2022 revision of the World Health Organization classification of tumors of the urinary system and male genital organs: Advances and challenges","volume":"136","author":"Mohanty","year":"2023","journal-title":"Hum Pathol"},{"key":"key20241202101834_b5-ol-29-1-14768","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1038\/s41416-023-02543-0","article-title":"Systemic anticancer therapy for urothelial carcinoma: UK oncologists' perspective","volume":"130","author":"Jones","year":"2024","journal-title":"Br J Cancer"},{"key":"key20241202101834_b6-ol-29-1-14768","doi-asserted-by":"publisher","first-page":"e076743","DOI":"10.1136\/bmj-2023-076743","article-title":"Advances in diagnosis and treatment of bladder cancer","volume":"384","author":"Lopez-Beltran","year":"2024","journal-title":"BMJ"},{"key":"key20241202101834_b7-ol-29-1-14768","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.eururo.2023.03.013","article-title":"European association of urology guidelines on upper urinary tract urothelial carcinoma: 2023 Update","volume":"84","author":"Roupr\u00eat","year":"2023","journal-title":"Eur Urol"},{"key":"key20241202101834_b8-ol-29-1-14768","doi-asserted-by":"publisher","first-page":"994351","DOI":"10.3389\/fpubh.2022.994351","article-title":"Clinicopathological characteristics and outcomes of synchronous renal cell carcinoma and urothelial carcinoma: A population-based analysis","volume":"10","author":"Wu","year":"2022","journal-title":"Front Public Health"},{"key":"key20241202101834_b9-ol-29-1-14768","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s12957-018-1321-x","article-title":"Concurrent renal cell carcinoma and urothelial carcinoma: Long-term follow-up study of 27 cases","volume":"16","author":"Qi","year":"2018","journal-title":"World J Surg Oncol"},{"key":"key20241202101834_b10-ol-29-1-14768","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1038\/modpathol.2009.9","article-title":"Differential expression of immunohistochemical markers in bladder smooth muscle and myofibroblasts, and the potential utility of desmin, smoothelin, and vimentin in staging of bladder carcinoma","volume":"22","author":"Council","year":"2009","journal-title":"Mod Pathol"},{"key":"key20241202101834_b11-ol-29-1-14768","doi-asserted-by":"publisher","first-page":"a001008","DOI":"10.1101\/cshperspect.a001008","article-title":"TP53 mutations in human cancers: Origins, consequences, and clinical use","volume":"2","author":"Olivier","year":"2010","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"key20241202101834_b12-ol-29-1-14768","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1007\/s12094-022-02994-6","article-title":"The prognostic role of p53 and its correlation with CDK9 in urothelial carcinoma","volume":"25","author":"Borowczak","year":"2023","journal-title":"Clin Transl Oncol"},{"key":"key20241202101834_b13-ol-29-1-14768","doi-asserted-by":"publisher","first-page":"e438640","DOI":"10.1200\/EDBK_438640","article-title":"Current advances in the management of nonurothelial subtypes of bladder cancer","volume":"44","author":"Vlachou","year":"2024","journal-title":"Am Soc Clin Oncol Educ Book"},{"key":"key20241202101834_b14-ol-29-1-14768","doi-asserted-by":"publisher","first-page":"S0","DOI":"10.4103\/jcrt.jcrt_1039_21","article-title":"Utility of GATA-3 and associated immunohistochemical markers in the differential diagnosis of poorly differentiated urothelial carcinoma","volume":"19","author":"Naik","year":"2023","journal-title":"J Cancer Res Ther"},{"key":"key20241202101834_b15-ol-29-1-14768","doi-asserted-by":"publisher","first-page":"4708154","DOI":"10.1155\/2019\/4708154","article-title":"Combined immunohistochemistry for the \u2018three 7\u2019 markers (CK7, CD117, and claudin-7) is useful in the diagnosis of chromophobe renal cell carcinoma and for the exclusion of mimics: Diagnostic experience from a single institution","volume":"2019","author":"Zhou","year":"2019","journal-title":"Dis Markers"},{"key":"key20241202101834_b16-ol-29-1-14768","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1136\/jclinpath-2014-202259","article-title":"PAX-8 expression in renal tumours and distant sites: A useful marker of primary and metastatic renal cell carcinoma?","volume":"68","author":"Barr","year":"2014","journal-title":"J Clin Pathol"},{"key":"key20241202101834_b17-ol-29-1-14768","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1007\/s00428-024-03872-y","article-title":"PAX8 expression in cancerous and non-neoplastic tissue: A tissue microarray study on more than 17,000 tumors from 149 different tumor entities","volume":"485","author":"Gorbokon","year":"2024","journal-title":"Virchows Arch"},{"key":"key20241202101834_b18-ol-29-1-14768","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1046\/j.1365-2559.2002.01408.x","article-title":"Expression of human mucin genes in normal kidney and renal cell carcinoma","volume":"40","author":"Leroy","year":"2002","journal-title":"Histopathology"},{"key":"key20241202101834_b19-ol-29-1-14768","first-page":"4595","article-title":"Clear cell papillary renal cell carcinoma: A clinicopathologic analysis of 6 cases","volume":"8","author":"Yan","year":"2015","journal-title":"Int J Clin Exp Pathol"},{"key":"key20241202101834_b20-ol-29-1-14768","article-title":"AJCC cancer staging manual","author":"Amin","year":"2017","edition":"8th edition"},{"key":"key20241202101834_b21-ol-29-1-14768","article-title":"Renal cancer","volume-title":"StatPearls [Internet]","author":"Pandey","year":"2024"},{"key":"key20241202101834_b22-ol-29-1-14768","article-title":"Bladder cancer","volume-title":"StatPearls","author":"Kaseb","year":"2023"},{"key":"key20241202101834_b23-ol-29-1-14768","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.1097\/01.ju.0000154351.37249.f0","article-title":"Using tumor markers to predict the survival of patients with metastatic renal cell carcinoma","volume":"173","author":"Kim","year":"2005","journal-title":"J Urol"},{"key":"key20241202101834_b24-ol-29-1-14768","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1309\/AJCP4NSKW5TLGTDS","article-title":"Immunohistochemistry for the novel markers glypican 3, PAX8, and p40 (\u0394Np63) in squamous cell and urothelial carcinoma","volume":"140","author":"Gailey","year":"2013","journal-title":"Am J Clin Pathol"},{"key":"key20241202101834_b25-ol-29-1-14768","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1007\/s00428-022-03361-0","article-title":"Immunohistochemistry subtyping of urothelial carcinoma is feasible in the daily practice","volume":"481","author":"Queipo","year":"2022","journal-title":"Virchows Arch"},{"article-title":"Chinese guidelines for diagnosis and treatment of urology and andrology diseases (2022 edition)","year":"2022","author":"Huang","key":"key20241202101834_b26-ol-29-1-14768"},{"key":"key20241202101834_b27-ol-29-1-14768","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1200\/JCO.2005.02.2574","article-title":"Activity of SU11248, a multitargeted inhibitor of vascular endothelial growth factor receptor and platelet-derived growth factor receptor, in patients with metastatic renal cell carcinoma","volume":"24","author":"Motzer","year":"2006","journal-title":"J Clin Oncol"},{"key":"key20241202101834_b28-ol-29-1-14768","doi-asserted-by":"publisher","first-page":"12","DOI":"10.21037\/cco.2015.12.02","article-title":"Chinese guidelines on the management of renal cell carcinoma (2015 edition)","volume":"5","author":"Guo","year":"2016","journal-title":"Chin Clin Oncol"},{"key":"key20241202101834_b29-ol-29-1-14768","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1111\/cas.14681","article-title":"Tislelizumab in Asian patients with previously treated locally advanced or metastatic urothelial carcinoma","volume":"112","author":"Ye","year":"2021","journal-title":"Cancer Sci"},{"key":"key20241202101834_b30-ol-29-1-14768","first-page":"37","article-title":"A programmed death receptor-1 inhibitor-Tislelizumab","volume":"20","author":"Liu","year":"2022","journal-title":"Clin Med J"},{"key":"key20241202101834_b31-ol-29-1-14768","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1002\/2211-5463.13102","article-title":"Tislelizumab uniquely binds to the CC' loop of PD-1 with slow-dissociated rate and complete PD-L1 blockage","volume":"11","author":"Hong","year":"2021","journal-title":"FEBS Open Bio"},{"key":"key20241202101834_b32-ol-29-1-14768","doi-asserted-by":"publisher","first-page":"2762","DOI":"10.1002\/1097-0142(19811215)48:12<2762::AID-CNCR2820481234>3.0.CO;2-E","article-title":"Simultaneous occurrence of renal cell adenocarcinoma and urothelial carcinoma of the renal pelvis in the same kidney diagnosed by preoperative angiography","volume":"48","author":"Yokoyama","year":"1981","journal-title":"Cancer"},{"key":"key20241202101834_b33-ol-29-1-14768","first-page":"405","article-title":"Multiple primary cancers limited to the urological field","volume":"47","author":"Oka","year":"2001","journal-title":"Hinyokika Kiyo"},{"key":"key20241202101834_b34-ol-29-1-14768","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/S0377-1237(06)80071-7","article-title":"A case of synchronous renal cell carcinoma (Rt) and transitional cell carcinoma urinary bladder","volume":"62","author":"Srinath","year":"2011","journal-title":"Med J Armed Forces India"},{"key":"key20241202101834_b35-ol-29-1-14768","first-page":"1261","article-title":"Clinical analysis of multiple primary malignant tumors and concurrent renal cell carcinoma","volume":"31","author":"Zhang","year":"2009","journal-title":"J Army Med Univ"},{"key":"key20241202101834_b36-ol-29-1-14768","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1097\/PAI.0b013e3181d57dce","article-title":"Clear cell carcinoma of the bladder in a patient with a earlier clear cell renal cell carcinoma: A case report with morphologic, immunohistochemical, and cytogenetical analysis","volume":"18","author":"Rotellini","year":"2010","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"key20241202101834_b37-ol-29-1-14768","first-page":"104","article-title":"Two separate synchronous primary genitourinary tumors","volume":"14","author":"Smith","year":"2012","journal-title":"Rev Urol"},{"key":"key20241202101834_b38-ol-29-1-14768","first-page":"993","article-title":"Clinical analysis of 21 cases of multiple primary cancers associated with bladder cancer in elderly patients","volume":"39","author":"Zhu","year":"2012","journal-title":"Chin J Clin Oncol"},{"key":"key20241202101834_b39-ol-29-1-14768","doi-asserted-by":"publisher","first-page":"101601","DOI":"10.1016\/j.eucr.2021.101601","article-title":"The first case report of synchronous primary papillary type 2 renal cell carcinoma of kidney and transitional cell carcinoma of bladder","volume":"37","author":"Djafari","year":"2021","journal-title":"Urol Case Rep"},{"key":"key20241202101834_b40-ol-29-1-14768","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1007\/BF02550608","article-title":"Triple malignancy of the genitourinary tract","volume":"20","author":"Dieckmann","year":"1988","journal-title":"Int Urol Nephrol"},{"key":"key20241202101834_b41-ol-29-1-14768","first-page":"675","article-title":"A case of synchronous triple primary cancers of prostate, kidney and bladder","volume":"44","author":"Harima","year":"1998","journal-title":"Hinyokika Kiyo"},{"key":"key20241202101834_b42-ol-29-1-14768","first-page":"239","article-title":"Synchronous triple urogenital cancer (renal cancer, bladder cancer, prostatic cancer): A case report","volume":"48","author":"Takada","year":"2002","journal-title":"Hinyokika Kiyo"},{"key":"key20241202101834_b43-ol-29-1-14768","first-page":"261","article-title":"A case of synchronous triple primary carcinomas of the kidney, bladder and prostate","volume":"49","author":"Satoh","year":"2003","journal-title":"Hinyokika Kiyo"},{"key":"key20241202101834_b44-ol-29-1-14768","first-page":"122","article-title":"A case of metachronous triple primary urogenital cancer: Urinary bladder, prostate, and renal cancer","volume":"32","author":"Arikan-Sengul","year":"2009","journal-title":"Onkologie"},{"key":"key20241202101834_b45-ol-29-1-14768","first-page":"39","article-title":"Case of bladder cancer following adjuvant external beam radiation for prostate cancer","volume":"55","author":"Nishikawa","year":"2009","journal-title":"Hinyokika Kiyo"},{"key":"key20241202101834_b46-ol-29-1-14768","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1159\/000343514","article-title":"Simultaneous cystectomy and nephroureterectomy due to synchronous upper urinary tract tumors and invasive bladder cancer: Open and laparoscopic approaches","volume":"6","author":"P\u00e9rez","year":"2012","journal-title":"Curr Urol"},{"key":"key20241202101834_b47-ol-29-1-14768","doi-asserted-by":"publisher","first-page":"786","DOI":"10.4103\/1319-2442.98161","article-title":"Synchronous primary cancers of urinary bladder and kidney and prostate","volume":"23","author":"Tiwari","year":"2012","journal-title":"Saudi J Kidney Dis Transpl"},{"key":"key20241202101834_b48-ol-29-1-14768","first-page":"702","article-title":"Case of heterochronous triple urogenital cancer (renal cell carcinoma, bladder cancer, prostatic cancer)","volume":"104","author":"Okumura","year":"2013","journal-title":"Nihon Hinyokika Gakkai Zasshi"},{"key":"key20241202101834_b49-ol-29-1-14768","doi-asserted-by":"publisher","first-page":"101277","DOI":"10.1016\/j.eucr.2020.101277","article-title":"Synchronous primary triple urogenital malignant tumors of kidney, prostate and bladder","volume":"33","author":"Kurose","year":"2020","journal-title":"Urol Case Rep"},{"key":"key20241202101834_b50-ol-29-1-14768","first-page":"861","article-title":"A case report of synchronous triple cancers in the urinary and male reproductive system","volume":"44","author":"Zhang","year":"2023","journal-title":"Chin J Urol"},{"key":"key20241202101834_b51-ol-29-1-14768","first-page":"823","article-title":"A case of renal cell carcinoma and bladder carcinoma associated with von Hippel-Lindau disease","volume":"36","author":"Kinbara","year":"1990","journal-title":"Hinyokika Kiyo"},{"key":"key20241202101834_b52-ol-29-1-14768","first-page":"831","article-title":"A case of double cancer: Renal cell carcinoma and transitional cell carcinoma of urinary bladder","volume":"36","author":"Nakano","year":"1990","journal-title":"Hinyokika Kiyo"},{"key":"key20241202101834_b53-ol-29-1-14768","first-page":"491","article-title":"A case of synchronous contralateral renal cell carcinoma and urothelial carcinoma","volume":"55","author":"Soda","year":"2009","journal-title":"Hinyokika Kiyo"},{"key":"key20241202101834_b54-ol-29-1-14768","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1111\/j.1442-2042.1996.tb00542.x","article-title":"A case of renal cell carcinoma associated with synchronous contralateral renal pelvic cancer and bladder tumor","volume":"3","author":"Ando","year":"1996","journal-title":"Int J Urol"},{"key":"key20241202101834_b55-ol-29-1-14768","first-page":"815","article-title":"A clinical analysis for 9 cases of multiple primary malignant neoplasms associated with renal cell carcinoma","volume":"18","author":"Lian","year":"2020","journal-title":"Oncol Prog"},{"key":"key20241202101834_b56-ol-29-1-14768","first-page":"1303","article-title":"A case of synchronous ipsilateral renal cell carcinoma and transitional cell carcinoma","volume":"37","author":"Tsujimura","year":"1991","journal-title":"Hinyokika Kiyo"},{"key":"key20241202101834_b57-ol-29-1-14768","first-page":"515","article-title":"Simultaneous development of renal cell carcinoma and multifocal urothelial carcinoma","volume":"31","author":"Chuang","year":"2008","journal-title":"Chang Gung Med J"},{"key":"key20241202101834_b58-ol-29-1-14768","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1002\/(SICI)1097-0274(199701)31:1<44::AID-AJIM7>3.0.CO;2-X","article-title":"Triple primary cancers involving kidney, urinary bladder, and liver in a dye worker","volume":"31","author":"Morikawa","year":"1997","journal-title":"Am J Ind Med"},{"key":"key20241202101834_b59-ol-29-1-14768","first-page":"705","article-title":"Ureteral and bladder metastases of renal cell carcinoma following synchronous renal cell carcinoma and bladder cancer; a case report","volume":"94","author":"Kamota","year":"2003","journal-title":"Nihon Hinyokika Gakkai Zasshi"},{"key":"key20241202101834_b60-ol-29-1-14768","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1097\/SMJ.0b013e3181a819c1","article-title":"A case of tubulocystic carcinoma simultaneously occurring with clear cell type renal cell carcinoma and micropapillary urothelial carcinoma of bladder","volume":"102","author":"G\u00f6n\u00fcl","year":"2009","journal-title":"South Med J"},{"key":"key20241202101834_b61-ol-29-1-14768","first-page":"691","article-title":"Cancerization of ureteral inverted papilloma complicated with ipsilateral renal cell cancer and bladder transitional cell carcinoma: One case report","volume":"22","author":"Wang","year":"2016","journal-title":"J Chin Oncol"},{"key":"key20241202101834_b62-ol-29-1-14768","first-page":"1141","article-title":"A case report of four primary malignant tumors","volume":"46","author":"Xu","year":"2019","journal-title":"Cancer Res Prev Treat"},{"key":"key20241202101834_b63-ol-29-1-14768","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1186\/s13256-021-03070-3","article-title":"A rare association in a patient with non-muscle invasive bladder cancer: Ureteral fibroepithelial polyp and ipsilateral renal cell carcinoma: A case report","volume":"15","author":"Akan","year":"2021","journal-title":"J Med Case Rep"},{"key":"key20241202101834_b64-ol-29-1-14768","first-page":"3242986","article-title":"Triple threat: Three primary malignancies simultaneously involving three genitourinary organs","volume":"2023","author":"Mitchell","year":"2023","journal-title":"Case Rep Urol"},{"key":"key20241202101834_b65-ol-29-1-14768","first-page":"383","article-title":"Multiple primary malignancies of the bladder, rectum and kidney: A case report","volume":"44","author":"Huang","year":"2023","journal-title":"Chin J Urol"},{"key":"key20241202101834_b66-ol-29-1-14768","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1016\/j.euo.2022.10.003","article-title":"Epidemiology, screening, and prevention of bladder cancer","volume":"5","author":"Lobo","year":"2022","journal-title":"Eur Urol Oncol"},{"key":"key20241202101834_b67-ol-29-1-14768","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1038\/s41572-023-00468-9","article-title":"Bladder cancer","volume":"9","author":"Dyrskj\u00f8t","year":"2023","journal-title":"Nat Rev Dis Primers"},{"key":"key20241202101834_b68-ol-29-1-14768","doi-asserted-by":"publisher","first-page":"3073","DOI":"10.21037\/tau.2020.03.23","article-title":"Radical cystectomy: A review of techniques, developments and controversies","volume":"9","author":"Aminoltejari","year":"2020","journal-title":"Transl Androl Urol"},{"key":"key20241202101834_b69-ol-29-1-14768","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1016\/j.eururo.2015.07.038","article-title":"A single-centre early phase randomised controlled three-arm trial of open, robotic, and laparoscopic radical cystectomy (CORAL)","volume":"69","author":"Khan","year":"2016","journal-title":"Eur Urol"},{"key":"key20241202101834_b70-ol-29-1-14768","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1097\/01.sla.0000133083.54934.ae","article-title":"Classification of surgical complications: A new proposal with evaluation in a cohort of 6336 patients and results of a survey","volume":"240","author":"Dindo","year":"2004","journal-title":"Ann Surg"},{"key":"key20241202101834_b71-ol-29-1-14768","doi-asserted-by":"publisher","first-page":"2171","DOI":"10.1200\/JCO.2010.32.3139","article-title":"International phase III trial assessing neoadjuvant cisplatin, methotrexate, and vinblastine chemotherapy for muscle-invasive bladder cancer: long-term results of the BA06 30894 trial","volume":"29","author":"Griffiths","year":"2011","journal-title":"J Clin Oncol"},{"key":"key20241202101834_b72-ol-29-1-14768","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.eururo.2005.04.006","article-title":"Neoadjuvant chemotherapy in invasive bladder cancer: update of a systematic review and meta-analysis of individual patient data advanced bladder cancer (ABC) meta-analysis collaboration","volume":"48","author":"Advanced Bladder Cancer (ABC) Meta-analysis Collaboration","year":"2005","journal-title":"Eur Urol"},{"key":"key20241202101834_b73-ol-29-1-14768","doi-asserted-by":"publisher","first-page":"1778","DOI":"10.1056\/NEJMoa2309863","article-title":"Nivolumab plus gemcitabine-cisplatin in advanced urothelial carcinoma","volume":"389","author":"van der Heijden","year":"2023","journal-title":"N Engl J Med"},{"key":"key20241202101834_b74-ol-29-1-14768","doi-asserted-by":"publisher","first-page":"3881","DOI":"10.1200\/JCO.22.02763","article-title":"Gemcitabine and cisplatin versus methotrexate, vinblastine, doxorubicin, and cisplatin in advanced or metastatic bladder cancer: Results of a large, randomized, multinational, multicenter, phase III study","volume":"41","author":"von der Maase","year":"2023","journal-title":"J Clin Oncol"},{"key":"key20241202101834_b75-ol-29-1-14768","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1056\/NEJMoa2002788","article-title":"Avelumab maintenance therapy for advanced or metastatic urothelial carcinoma","volume":"383","author":"Powles","year":"2020","journal-title":"N Engl J Med"},{"key":"key20241202101834_b76-ol-29-1-14768","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1007\/s00262-024-03682-w","article-title":"Global real-world experiences with pembrolizumab in advanced urothelial carcinoma after platinum-based chemotherapy: The ARON-2 study","volume":"73","author":"Massari","year":"2024","journal-title":"Cancer Immunol Immunother"},{"key":"key20241202101834_b77-ol-29-1-14768","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1016\/j.juro.2017.04.086","article-title":"Treatment of non-metastatic muscle-invasive bladder cancer: AUA\/ASCO\/ASTRO\/SUO guideline","volume":"198","author":"Chang","year":"2017","journal-title":"J Urol"},{"key":"key20241202101834_b78-ol-29-1-14768","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/j.annonc.2024.03.001","article-title":"ESMO clinical practice guideline interim update on first-line therapy in advanced urothelial carcinoma","volume":"35","author":"Powles","year":"2024","journal-title":"Ann Oncol"},{"key":"key20241202101834_b79-ol-29-1-14768","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.euo.2024.02.010","article-title":"The overall survival benefit in EV-302: Is enfortumab vedotin plus pembrolizumab the new frontline standard of care for metastatic urothelial carcinoma?","volume":"7","author":"Benjamin","year":"2024","journal-title":"Eur Urol Oncol"},{"key":"key20241202101834_b80-ol-29-1-14768","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1093\/ndt\/gfae036","article-title":"Global epidemiology of kidney cancer","volume":"39","author":"Cirillo","year":"2024","journal-title":"Nephrol Dial Transplant"},{"key":"key20241202101834_b81-ol-29-1-14768","doi-asserted-by":"publisher","first-page":"e2116","DOI":"10.1002\/cnr2.2116","article-title":"Diagnostic, predictive and prognostic molecular biomarkers in clear cell renal cell carcinoma: A retrospective study","volume":"7","author":"Deng","year":"2024","journal-title":"Cancer Rep (Hoboken)"},{"key":"key20241202101834_b82-ol-29-1-14768","doi-asserted-by":"publisher","first-page":"13710","DOI":"10.1038\/s41598-024-59905-8","article-title":"Kidney cancer in the Middle East and North Africa region: A 30-year analysis (1990\u20132019)","volume":"14","author":"Safiri","year":"2024","journal-title":"Sci Rep"},{"key":"key20241202101834_b83-ol-29-1-14768","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1002\/ijc.20618","article-title":"Renal cell carcinoma in relation to cigarette smoking: Meta-analysis of 24 studies","volume":"114","author":"Hunt","year":"2005","journal-title":"Int J Cancer"},{"key":"key20241202101834_b84-ol-29-1-14768","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1038\/nrurol.2010.46","article-title":"Epidemiology and risk factors for kidney cancer","volume":"7","author":"Chow","year":"2010","journal-title":"Nat Rev Urol"},{"key":"key20241202101834_b85-ol-29-1-14768","doi-asserted-by":"publisher","first-page":"107181","DOI":"10.1016\/j.phrs.2024.107181","article-title":"Combination immune checkpoint and targeted protein kinase inhibitors for the treatment of renal cell carcinomas","volume":"203","author":"Roskoski","year":"2024","journal-title":"Pharmacol Res"},{"key":"key20241202101834_b86-ol-29-1-14768","doi-asserted-by":"publisher","first-page":"17009","DOI":"10.1038\/nrdp.2017.9","article-title":"Renal cell carcinoma","volume":"3","author":"Hsieh","year":"2017","journal-title":"Nat Rev Dis Primers"},{"key":"key20241202101834_b87-ol-29-1-14768","doi-asserted-by":"publisher","first-page":"1362172","DOI":"10.3389\/fonc.2024.1362172","article-title":"Perioperative systemic treatments in renal cell carcinoma","volume":"14","author":"Goswamy","year":"2024","journal-title":"Front Oncol"},{"key":"key20241202101834_b88-ol-29-1-14768","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.urolonc.2024.04.002","article-title":"Avoiding \u2018Needless\u2019 nephrectomy: What is the role of small renal mass biopsy in 2024?","volume":"42","author":"Gao","year":"2024","journal-title":"Urol Oncol"},{"key":"key20241202101834_b89-ol-29-1-14768","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.juro.2014.07.102","article-title":"Preoperatively misclassified, surgically removed benign renal masses: A systematic review of surgical series and United States population level burden estimate","volume":"193","author":"Johnson","year":"2015","journal-title":"J Urol"},{"key":"key20241202101834_b90-ol-29-1-14768","first-page":"1358","article-title":"Multiple primary malignant tumors, a survey of the literature and a statistical study","volume":"16","author":"Warren","year":"1932","journal-title":"Am J Cancer"},{"key":"key20241202101834_b91-ol-29-1-14768","doi-asserted-by":"publisher","first-page":"e000172","DOI":"10.1136\/esmoopen-2017-000172","article-title":"Multiple primary tumours: Challenges and approaches, a review","volume":"2","author":"Vogt","year":"2017","journal-title":"ESMO Open"},{"key":"key20241202101834_b92-ol-29-1-14768","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.urology.2020.05.067","article-title":"Gender differences in incidence, diagnosis, treatments, and outcomes in clinically localized bladder and renal cancer","volume":"151","author":"Gul","year":"2021","journal-title":"Urology"},{"key":"key20241202101834_b93-ol-29-1-14768","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1097\/01.ju.0000052373.36963.12","article-title":"Familial papillary renal cell tumors and subsequent cancers: A nationwide epidemiological study from Sweden","volume":"169","author":"Czene","year":"2003","journal-title":"J Urol"},{"key":"key20241202101834_b94-ol-29-1-14768","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/S0090-4295(00)00682-8","article-title":"Second primary malignancies associated with renal cell carcinoma: Influence of histologic type","volume":"56","author":"Rabbani","year":"2000","journal-title":"Urology"},{"key":"key20241202101834_b95-ol-29-1-14768","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/j.urolonc.2010.04.013","article-title":"Clinical features and prognosis of patients with renal cancer and a second malignancy","volume":"30","author":"Antonelli","year":"2012","journal-title":"Urol Oncol"},{"key":"key20241202101834_b96-ol-29-1-14768","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/j.ajur.2022.05.009","article-title":"Genitourinary manifestations of Lynch syndrome in the urological practice","volume":"9","author":"Lonati","year":"2022","journal-title":"Asian J Urol"},{"key":"key20241202101834_b97-ol-29-1-14768","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1093\/jnci\/djh034","article-title":"Revised Bethesda guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability","volume":"96","author":"Umar","year":"2004","journal-title":"J Natl Cancer Inst"},{"key":"key20241202101834_b98-ol-29-1-14768","doi-asserted-by":"publisher","first-page":"506","DOI":"10.3390\/cancers15020506","article-title":"Relative risk of bladder and kidney cancer in lynch syndrome: Systematic review and meta-analysis","volume":"15","author":"Nassour","year":"2023","journal-title":"Cancers (Basel)"},{"key":"key20241202101834_b99-ol-29-1-14768","doi-asserted-by":"publisher","first-page":"102536","DOI":"10.1016\/j.canep.2024.102536","article-title":"Risk of secondary primary malignancies in survivors of upper tract urothelial carcinoma: A nationwide population-based analysis","volume":"89","author":"Wu","year":"2024","journal-title":"Cancer Epidemiol"}],"container-title":["Oncology Letters"],"original-title":[],"deposited":{"date-parts":[[2024,12,2]],"date-time":"2024-12-02T08:18:45Z","timestamp":1733127525000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/ol.2024.14768"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,23]]},"references-count":99,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,10,23]]}},"URL":"https:\/\/doi.org\/10.3892\/ol.2024.14768","relation":{},"ISSN":["1792-1074","1792-1082"],"issn-type":[{"type":"print","value":"1792-1074"},{"type":"electronic","value":"1792-1082"}],"subject":[],"published":{"date-parts":[[2024,10,23]]},"article-number":"21"}}